Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors
Completed · Not applicable
Conditions studied: Brain Tumor
In brief
This research will leverage novel pilot research conducted by the investigators to take important first steps in addressing neurocognitive late effects by intervening early, during treatment, with a promising computerized cognitive remediation program to prevent the downward trajectory of neurocognitive function experienced by pediatric brain tumor survivors. Specifically, we propose to test the feasibility, acceptability, and initial proof of concept of a neuroplasticity-based adaptive cognitive training program (Cogmed) to train working memory (WM) and attention in newly diagnosed youth with a brain tumor. Further, we will test the feasibility of using this intervention in a true prospective design beginning pre-surgery to examine the effects of this intervention in deflecting the downward trajectory of cognitive function in children with brain tumors during treatment. We will also use functional neuroimaging (near infrared spectroscopy - "NIRS") to examine the effects of this program on brain activation in frontal regions that are affected by treatment. Findings from this pilot study will inform the development of a large multi-site randomized efficacy trial to test an individualized cognitive training program. Aim 1. To test the feasibility and acceptability of enrolling youth (7 to 16 years-old) with newly diagnosed brain tumors at time of diagnosis, following patients for 10 weeks, delivering the Cogmed computer-based training program in a randomized trial at 10-weeks post-diagnosis, and following patients to 1 year post-diagnosis. Aim 2. To test the initial acceptability and efficacy of the Cogmed training program on cognitive function in newly diagnosed pediatric brain tumor patients.
Key facts
- Study ID
- NCT02129712
- Run by
- Vanderbilt University
- People needed
- 40
- Starts
- 2014-02-01
- Expected to finish
- 2017-12-31
- Last updated by the study team
- 2018-09-06
Who can join
Age: 7 and older, up to 16. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Newly diagnosed brain tumor patients who are between the ages of 7 years and 16 years, 11 months old and their parents
- Patients and their parents must be fluent English speakers
You may not qualify if…
- Patient's brain tumor diagnosis cannot be a recurrence of a previous cancer
- No previous history of another form of cancer
- Patients who are deemed legally blind will be excluded from participating
Where it is running
- Vanderbilt University — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.